treatment. Despite the fact that a higher percentage
(43.3% vs 33.1%; P < .0001) of the patients in the endovascular group had a Charlson Comorbidity Index score of 2
or higher, they had a lower mortality rate (2.4% vs 8.7%;
P < .0001), mean length of stay (6.3 days vs 14.0 days;
P